Hyung-jo Choi is a correspondent based in MLex’s Seoul office, South Korea, covering anti-trust, privacy and data security, mergers and acquisitions and financial services. Previously, he worked for the Korea JoongAng Daily, one of the three English-only daily newspapers in South Korea, mainly focusing on South Korean government’s economic and financial policies.
Hyung-jo graduated from Yonsei University in South Korea with a degree in International Studies.
Selected Insights by Hyung-jo
Regulatory overlap and turf wars in S Korea, from a request to the Korea Fair Trade Commission to refer McDonald’s Korea for franchise law and subcontracting allegations.
US DOJ says a former exec of Continental Automotive Korea was extradited to the US and pleaded guilty for his role in a global auto-parts cartel.
CCPA presents regulatory concerns for companies in Seoul but could lead to changes in South Korean privacy lawSouth Korean companies targeting the US market are likely to feel the regulatory tremors created by the new privacy law in California, especially those in the gaming and IT industries, sectors where the US market is perhaps the most lucrative.
Seven executives of various pharmaceutical companies and distributors, including an executive of the local branch of French pharma giant Sanofi, have been arrested by the South Korean prosecutors' office as part of its first independent antitrust probe, which is targeting bid-rigging schemes in public tenders for vaccines and is likely to expand to cover more major South Korean and global pharmaceutical companies, MLex has learned.
Pharma executives, distributors arrested by South Korean prosecutors for rigging bids on public tenders for vaccines, in a probe that could stretch to more than 50 companiesSeveral executives of South Korean pharmaceutical companies have been arrested by the country’s prosecutors’ office in its first independent antitrust probe since the inauguration of the new prosecutor-general, with investigators suspecting collusive schemes on public tenders among dozens of vaccine producers and distributors covering a wide swathe of the South Korean vaccine market.